Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Raskin

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
Treatments in Endocrinology|August 2, 2005
Thiazolidinediones and insulin: rationale for use and role of combination therapy in type 2 diabetes mellitusAlvin Huang, Philip Raskin
Vascular Health and Risk Management|May 14, 2009
Vascular effects of rapid-acting insulin analogs in the diabetic patient: a reviewSteve Fordan, Philip Raskin
Journal of Diabetes and Its Complications|June 1, 2002
Diabetic hypertriglyceridemia-induced acute pancreatitis masquerading as biliary pancreatitisDavid B Huang, Philip Raskin
Diabetes Care|June 29, 2005
The effect of rosiglitazone on overweight subjects with type 1 diabetesSuzanne M Strowig, Philip Raskin
Hospital Practice (1995)|October 23, 2012
Managing inpatient hyperglycemia in a resource-constrained county hospital: the Parkland Memorial Hospital experienceErin D Roe, Philip Raskin
Current Diabetes Reports|March 20, 2003
Blood pressure control--effects on diabetic nephropathy progression: how low does blood pressure have to be?Christopher A Newton, Philip Raskin
Clinical Medicine Insights. Endocrinology and Diabetes|August 11, 2012
Updated review: improved glycemic control with repaglinide-metformin in fixed combination for patients with type 2 diabetesJohn W Richard, Philip Raskin
Archives of Internal Medicine|September 29, 2004
Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differencesChristopher A Newton, Philip Raskin
Diabetes, Obesity & Metabolism|October 13, 2005
Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitusSuzanne M Strowig, Philip Raskin
Expert Review of Endocrinology & Metabolism|July 31, 2018
Bromocriptine-QR therapy for the management of type 2 diabetes mellitus: developmental basis and therapeutic profile summaryPhilip Raskin, Anthony H Cincotta
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Treatments in Endocrinology|August 2, 2005
Thiazolidinediones and insulin: rationale for use and role of combination therapy in type 2 diabetes mellitusAlvin Huang, Philip Raskin
Vascular Health and Risk Management|May 14, 2009
Vascular effects of rapid-acting insulin analogs in the diabetic patient: a reviewSteve Fordan, Philip Raskin
Journal of Diabetes and Its Complications|June 1, 2002
Diabetic hypertriglyceridemia-induced acute pancreatitis masquerading as biliary pancreatitisDavid B Huang, Philip Raskin
Diabetes Care|June 29, 2005
The effect of rosiglitazone on overweight subjects with type 1 diabetesSuzanne M Strowig, Philip Raskin
Hospital Practice (1995)|October 23, 2012
Managing inpatient hyperglycemia in a resource-constrained county hospital: the Parkland Memorial Hospital experienceErin D Roe, Philip Raskin
Current Diabetes Reports|March 20, 2003
Blood pressure control--effects on diabetic nephropathy progression: how low does blood pressure have to be?Christopher A Newton, Philip Raskin
Clinical Medicine Insights. Endocrinology and Diabetes|August 11, 2012
Updated review: improved glycemic control with repaglinide-metformin in fixed combination for patients with type 2 diabetesJohn W Richard, Philip Raskin
Archives of Internal Medicine|September 29, 2004
Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differencesChristopher A Newton, Philip Raskin
Diabetes, Obesity & Metabolism|October 13, 2005
Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitusSuzanne M Strowig, Philip Raskin
Expert Review of Endocrinology & Metabolism|July 31, 2018
Bromocriptine-QR therapy for the management of type 2 diabetes mellitus: developmental basis and therapeutic profile summaryPhilip Raskin, Anthony H Cincotta
Pageof 13